Markets

Market

News Details

(29/09/2026 10:25)

Natco Pharma raises investment in eGenesis to $16.7 mn

Natco Pharma Ltd has increased its proposed investment in US-based biotechnology firm eGenesis Inc to $16.7 million (around Rs 139 crore) from the earlier disclosed amount of $14 million.

Under the revised structure, NATCO Pharma (Canada) Inc will invest $13.7 million, while NATCO Pharma USA LLC will contribute $3 million, according to a regulatory filing.

The investment involves the purchase of convertible promissory notes carrying 8% annual compounded interest. No additional shares will be acquired at the time of completion, with the transaction expected to close by October 31.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.